BioBrit

About The Fund

BioBrit is a life sciences consulting and investment firm located in La Jolla, California, focusing on transformative strategies for businesses in the biotech and pharmaceutical sectors. The firm is distinguished by its expertise in bringing novel medicines to market and maximizing shareholder value, leveraging over 40 years of industry experience through its managing member, Dan Bradbury, a seasoned executive with an extensive background in the life sciences sector, including biopharmaceutical companies focused on metabolic diseases. BioBrit operates with an investment range between $100,000 and $5,000,000, preferring investments around the $1,500,000 'sweet spot.' Specializing in Seed, Series A, and Pre-seed funding stages, BioBrit seeks to empower companies that show high potential in the BioTech and Pharmaceutical sectors. With a history of successful ventures, including the introduction of first-in-class medicines and a record of leadership in biopharmaceutical companies listed on Nasdaq, BioBrit brings a wealth of knowledge and experience to its investments. Their leader, Dan Bradbury, has been instrumental in creating first-weekly therapies for diabetes and has served as CEO of a biopharmaceutical company acquired by a major corporation. BioBrit's current and past portfolio, along with their board services, showcase their commitment to advancing medical innovations that address unmet medical needs, supporting businesses from their foundation to successful exits or clinical advancements.